Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Preclinical
Sponsor : Eos Advisory
Deal Size : $11.4 million
Deal Type : Financing
Cumulus Oncology Raises £9m in Seed Financing
Details : The proceeds will be used to accelerate the development of drug discovery programmes in the area of DNA damage response, towards clinical Proof of Concept.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
August 01, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Sponsor : Eos Advisory
Deal Size : $11.4 million
Deal Type : Financing
Details : Under the collaboration, the companies will focus on the discovery and development of small molecules targeting an undisclosed and novel cancer-focused G protein-coupled receptor (GPCR).
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
July 17, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery
Recipient : Nodus Oncology
Deal Size : Undisclosed
Deal Type : Financing
Details : The financing will be used to expand and develop Nodus’ portfolio of first-in-class and best in class assets. LDC will act as the drug discovery arm of Nodus and participate in the development of all assets in Nodus’ pipeline.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
June 09, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery
Recipient : Nodus Oncology
Deal Size : Undisclosed
Deal Type : Financing
Reset All
